TissGeneSummary for RGR |
Gene summary |
Basic gene information | Gene symbol | RGR |
Gene name | retinal G protein coupled receptor | |
Synonyms | RP44 | |
Cytomap | UCSC genome browser: 10q23 | |
Type of gene | protein-coding | |
RefGenes | NM_001012720.1, NM_001012722.1,NM_002921.3, | |
Description | RGR-opsinRPE retinal G-protein coupled receptorRPE-retinal G protein-coupled receptor | |
Modification date | 20141219 | |
dbXrefs | MIM : 600342 | |
HGNC : HGNC | ||
Ensembl : ENSG00000148604 | ||
HPRD : 02642 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_RGR | |
BioGPS: 5995 | ||
Pathway | NCI Pathway Interaction Database: RGR | |
KEGG: RGR | ||
REACTOME: RGR | ||
Pathway Commons: RGR | ||
Context | iHOP: RGR | |
ligand binding site mutation search in PubMed: RGR | ||
UCL Cancer Institute: RGR | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,TiGER | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | BrainEye | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | GBM,LGGUVM | |
Reference showing the relevant tissue of RGR | ||
Description by TissGene annotations | Protective TissGene in OS Protective TissGene in RFS TissgsKTS CNV lost TissGeneKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for RGR |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
Top |
TissGene-miRNA for RGR |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for RGR |
TissGeneSNV for RGR |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.S171Y | PAAD | 1 |
p.A72P | THYM | 1 |
p.H82N | LUAD | 1 |
p.G173R | SKCM | 1 |
p.R84C | STAD | 1 |
p.A112D | LUAD | 1 |
p.S81F | SKCM | 1 |
p.P220S | UCEC | 1 |
p.R218K | SKCM | 1 |
p.R80C | STAD | 1 |
p.D242Y | UCEC | 1 |
p.T263M | UCEC | 1 |
p.G163V | UCEC | 1 |
p.V139A | UCEC | 1 |
p.A241T | PRAD | 1 |
p.L149V | BLCA | 1 |
p.P230S | GBM | 1 |
p.S114F | CESC | 1 |
p.L284P | LIHC | 1 |
p.T174S | THCA | 1 |
p.K209N | HNSC | 1 |
p.H95Y | SKCM | 1 |
p.L219V | HNSC | 1 |
p.T178S | THCA | 1 |
p.I257V | ESCA | 1 |
p.L219V | BLCA | 1 |
p.G45R | PRAD | 1 |
p.A39S | LUAD | 1 |
p.K205Q | SKCM | 1 |
p.R222K | SKCM | 1 |
p.S199F | SKCM | 1 |
p.G223D | SKCM | 1 |
p.D48N | SKCM | 1 |
p.G227D | SKCM | 1 |
p.P53S | SKCM | 1 |
p.A103V | UCEC | 1 |
p.G229D | BLCA | 1 |
p.T219K | HNSC | 1 |
p.W115* | SKCM | 1 |
p.K205N | HNSC | 1 |
p.A186V | STAD | 1 |
p.K209Q | SKCM | 1 |
p.L151F | SKCM | 1 |
p.T223K | HNSC | 1 |
p.G82R | SKCM | 1 |
p.E290D | SKCM | 1 |
p.A190V | STAD | 1 |
Top |
TissGeneCNV for RGR |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for RGR |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for RGR |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for RGR |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for RGR |
TissGeneDrug for RGR |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for RGR |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0035334 | Retinitis Pigmentosa | 4 | BeFree,CTD_human,GAD,ORPHANET |
umls:C0483368 | Human anaplasmosis due to Anaplasma phagocytophilum | 4 | BeFree |
umls:C0854723 | Retinal Dystrophies | 2 | BeFree,GAD |
umls:C0024198 | Lyme Disease | 1 | BeFree |
umls:C0035304 | Retinal Degeneration | 1 | LHGDN |
umls:C0035309 | Retinal Diseases | 1 | GAD |
umls:C0085648 | Synovial Cyst | 1 | BeFree |
umls:C0242383 | Age related macular degeneration | 1 | BeFree |
umls:C1258666 | Myxoid cyst | 1 | BeFree |
umls:C1260959 | Drusen | 1 | BeFree |
umls:C3151068 | RETINITIS PIGMENTOSA 44 | 1 | CLINVAR,UNIPROT |